Jana McAninch

875 total citations · 1 hit paper
17 papers, 636 citations indexed

About

Jana McAninch is a scholar working on Public Health, Environmental and Occupational Health, Emergency Medicine and Anesthesiology and Pain Medicine. According to data from OpenAlex, Jana McAninch has authored 17 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Public Health, Environmental and Occupational Health, 8 papers in Emergency Medicine and 6 papers in Anesthesiology and Pain Medicine. Recurrent topics in Jana McAninch's work include Opioid Use Disorder Treatment (13 papers), Poisoning and overdose treatments (7 papers) and Pain Management and Opioid Use (6 papers). Jana McAninch is often cited by papers focused on Opioid Use Disorder Treatment (13 papers), Poisoning and overdose treatments (7 papers) and Pain Management and Opioid Use (6 papers). Jana McAninch collaborates with scholars based in United States and South Africa. Jana McAninch's co-authors include Christopher M. Jones, Catherine S. Hwang, Cynthia Kornegay, Judy A. Staffa, Elizabeth M. Kang, Silvia N. Calderon, Sara Karami, Jacqueline M. Major, Eileen Wu and Cindy Kortepeter and has published in prestigious journals such as PLoS ONE, American Journal of Preventive Medicine and JAMA Network Open.

In The Last Decade

Jana McAninch

15 papers receiving 607 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emergency Department Visits and Overdose Deaths From Combined Use of Opioids and Benzodiazepines

2015 302 citations Christopher M. Jones, Jana McAninch American Journal of Preventive Medicine profile →

Peers

Countries citing papers authored by Jana McAninch

Since Specialization

Citations

This map shows the geographic impact of Jana McAninch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jana McAninch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jana McAninch more than expected).

Fields of papers citing papers by Jana McAninch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jana McAninch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jana McAninch. The network helps show where Jana McAninch may publish in the future.

Co-authorship network of co-authors of Jana McAninch

This figure shows the co-authorship network connecting the top 25 collaborators of Jana McAninch. A scholar is included among the top collaborators of Jana McAninch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jana McAninch. Jana McAninch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Title	Journal	Authors	Indexed citations
1	Trends and characteristics during 17 years of naloxone distribution and administration through an overdose prevention program in Pittsburgh, Pennsylvania	PLoS ONE	Nabarun Dasgupta, Alice Bell et al.	0
2	Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality	Journal of Addiction Medicine	Feitong Lei, Michelle R. Lofwall et al.	5
3	Drugs involved in Kentucky drug poisoning deaths and relation with antecedent controlled substance prescription dispensing	Substance Abuse Treatment Prevention and Policy	Patricia R. Freeman, Jana McAninch et al.	0
4	Characteristics and Prescribing Patterns of Clinicians Waivered to Prescribe Buprenorphine for Opioid Use Disorder Before and After Release of New Practice Guidelines	JAMA Health Forum	Christopher M. Jones, Yngvild Olsen et al.	20
5	The impact of hydrocodone rescheduling on utilization, abuse, misuse, and overdose deaths	Pharmacoepidemiology and Drug Safety	Sara Karami, Adebola Ajao et al.	1
6	Patient-Reported Opioid Analgesic Use After Discharge from Surgical Procedures: A Systematic Review	Pain Medicine	Jana McAninch, Gerald J. Dal Pan et al.	3
7	Emergency Department Visits Attributed to Adverse Events Involving Benzodiazepines, 2016–2017	American Journal of Preventive Medicine	Ruth N. Moro, Andrew I. Geller et al.	14
8	U.S. Emergency Department Visits Resulting From Nonmedical Use of Pharmaceuticals, 2016	American Journal of Preventive Medicine	Andrew I. Geller, Deborah Dowell et al.	21
9	A comparison of opioid‐involved fatalities captured in the National Poison Data System to data derived from US death certificate literal text	Pharmacoepidemiology and Drug Safety	James P. Trinidad, Yueqin Zhao et al.	12
10	Patterns of Immediate-Release and Extended-Release Opioid Analgesic Use in the Management of Chronic Pain, 2003-2014	JAMA Network Open	Catherine S. Hwang, Elizabeth M. Kang et al.	11
11	Trends in dextromethorphan cough and cold products: 2000–2015 National Poison Data System intentional abuse exposure calls	Clinical Toxicology	Sara Karami, Jacqueline M. Major et al.	26
12	Adverse event detection using the FDA post-marketing drug safety surveillance system: Cardiotoxicity associated with loperamide abuse and misuse	Journal of the American Pharmacists Association	Eileen Wu, Cindy Kortepeter et al.	32
13	Important statistical considerations in the evaluation of post‐market studies to assess whether opioids with abuse‐deterrent properties result in reduced abuse in the community	Pharmacoepidemiology and Drug Safety	Kunthel By, Jana McAninch et al.	9
14	Trends in the Concomitant Prescribing of Opioids and Benzodiazepines, 2002−2014	American Journal of Preventive Medicine	Catherine S. Hwang, Elizabeth M. Kang et al.	142
15	Emergency Department Visits and Overdose Deaths From Combined Use of Opioids and Benzodiazepines breakdown →	American Journal of Preventive Medicine	Christopher M. Jones, Jana McAninch	302
16	Higher psychological distress is associated with unintentional injuries in US adults	Injury Prevention	Jana McAninch, John D. Sorkin et al.	24
17	Paying for Reproductive Health Care: What is Needed, and What is Available?	International Family Planning Perspectives	Malcolm Potts, Julia Walsh et al.	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact